Cargando…

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Yihan, Zhou, Yunxiang, Liu, Lihong, Xu, Yanyan, Chen, Qiang, Wang, Yali, Wu, Shijie, Deng, Yongchuan, Zhang, Jianmin, Shao, Anwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468194/ https://www.ncbi.nlm.nih.gov/pubmed/32974385 http://dx.doi.org/10.3389/fmolb.2020.00193

Ejemplares similares

Nanotechnology in Drug Delivery for Liver Fibrosis
por: Gu, Lihong, et al.
Publicado: (2022)

Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
por: Scioli Montoto, Sebastián, et al.
Publicado: (2020)

A promising nucleic acid therapy drug: DNAzymes and its delivery system
por: Xiao, Lang, et al.
Publicado: (2023)

Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy
por: Zhang, Mingxin, et al.
Publicado: (2022)

Nanogels as novel drug nanocarriers for CNS drug delivery
por: Manimaran, V., et al.
Publicado: (2023)

Primary cilia: a novel research approach to overcome anticancer drug resistance
por: Lee, Kyung Ho
Publicado: (2023)

The role and therapeutic potential of heat shock proteins in haemorrhagic stroke
por: Shao, Anwen, et al.
Publicado: (2019)

Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury
por: Zhou, Yunxiang, et al.
Publicado: (2020)

Regulation of efferocytosis as a novel cancer therapy
por: Zhou, Yunxiang, et al.
Publicado: (2020)

Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors
por: Cheng, Xiaoliang, et al.
Publicado: (2020)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery
por: Zhang, Yiming, et al.
Publicado: (2023)

Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery
por: Bunker, Alex, et al.
Publicado: (2020)

Analysis and Construction of a Molecular Diagnosis Model of Drug-Resistant Epilepsy Based on Bioinformatics
por: Han, Tenghui, et al.
Publicado: (2021)

Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
por: Kumari, Ankita, et al.
Publicado: (2022)

Corrigendum: Phenotype-based drug screening: An in vivo strategy to classify and identify the chemical compounds modulating zebrafish M-cell regeneration
por: Kumari, Ankita, et al.
Publicado: (2023)

Antibacterial and antibiofilm activity of Abroma augusta stabilized silver (Ag) nanoparticles against drug-resistant clinical pathogens
por: Kumar, Sachin, et al.
Publicado: (2023)

Overcoming Chemoresistance via Extracellular Vesicle Inhibition
por: Hayatudin, Raeesah, et al.
Publicado: (2021)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
por: Palomba, Roberto, et al.
Publicado: (2023)

BSA-Stabilized Mesoporous Organosilica Nanoparticles Reversed Chemotherapy Resistance of Anaplastic Thyroid Cancer by Increasing Drug Uptake and Reducing Cellular Efflux
por: Han, Xiao, et al.
Publicado: (2020)

Drugging Fuzzy Complexes in Transcription
por: Su, Bonnie G., et al.
Publicado: (2021)

The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance
por: Cao, Shulong, et al.
Publicado: (2021)

Highly improved pH-Responsive anticancer drug delivery and T2-Weighted MRI imaging by magnetic MOF CuBTC-based nano/microcomposite
por: Gharehdaghi, Zahra, et al.
Publicado: (2023)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
por: Scala, Maria Carmina, et al.
Publicado: (2021)

Evolution and intelligent design in drug development
por: Agafonov, Roman V., et al.
Publicado: (2015)

Inteins as Drug Targets and Therapeutic Tools
por: Tharappel, Anil Mathew, et al.
Publicado: (2022)

Natural antisense transcripts as drug targets
por: Khorkova, Olga, et al.
Publicado: (2022)

Principles and functions of condensate modifying drugs
por: Patel, Avinash, et al.
Publicado: (2022)

A Novel Hybrid Logic-ODE Modeling Approach to Overcome Knowledge Gaps
por: Selvaggio, Gianluca, et al.
Publicado: (2021)

Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
por: Scala, Maria Carmina, et al.
Publicado: (2022)

Drug discovery by a basic research scientist
por: Eaton, William A.
Publicado: (2022)

Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development
por: Padmanabha Das, Krishna M.
Publicado: (2023)

Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
por: Wu, Xialin, et al.
Publicado: (2023)

Uncovering the Mechanism of Drug Resistance Caused by the T790M Mutation in EGFR Kinase From Absolute Binding Free Energy Calculations
por: Zhou, Huaxin, et al.
Publicado: (2022)

Chitosan, polyethylene oxide/polycaprolactone electrospun core/shell nanofibrous mat containing rosuvastatin as a novel drug delivery system for enhancing human mesenchymal stem cell osteogenesis
por: Ghasemvand, Fariba, et al.
Publicado: (2023)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
por: Wang, Huailan, et al.
Publicado: (2021)

Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020)

Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_781mpf2khduucujt5ahfes4teg